Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Islamic Fasting and Multiple Sclerosis Publisher Pubmed



Jahromi SR1 ; Sahraian MA1 ; Ashtari F2 ; Ayromlou H3 ; Etemadifar M11 ; Ghaffarpour M4 ; Mohammadianinejad E5 ; Nafissi S6 ; Nickseresht A7 ; Shaygannejad V8 ; Togha M1 ; Torabi HR9 ; Ziaie S10
Authors
Show Affiliations
Authors Affiliations
  1. 1. MS Research Center, Neuroscience Institute, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Neurology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Iranian Center for Neurological Research, Imam Khomini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Neurology, Golestan Hospital, Ahwaz University of Medical Sciences, Ahwaz, Iran
  6. 6. Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Neurology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Department of Neurology, Kashani Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  9. 9. Jam Hospital, Iranian MS Society, Tehran, Iran
  10. 10. Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  11. 11. Iran MS and Neuroimmunology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: BMC Neurology Published:2014


Abstract

Background: Month-long daytime Ramadan fasting pose s major challenges to multiple sclerosis (MS) patients in Muslim countries. Physicians should have practical knowledge on the implications of fasting on MS. We present a summary of database searches (Cochrane Database of Systematic Reviews, PubMed) and a mini-symposium on Ramadan fasting and MS. In this symposium, we aimed to review the effect of fasting on MS and suggest practical guidelines on management.Discussion: In general, fasting is possible for most stable patients. Appropriate amendment of drug regimens, careful monitoring of symptoms, as well as providing patients with available evidence on fasting and MS are important parts of management. Evidence from experimental studies suggests that calorie restriction before disease induction reduces inflammation and subsequent demyelination and attenuates disease severity. Fasting does not appear to have unfavorable effects on disease course in patients with mild disability (Expanded Disability Status Scale (EDSS) score ≤3). Most experts believed that during fasting (especially in summer), some MS symptoms (fatigue, fatigue perception, dizziness, spasticity, cognitive problems, weakness, vision, balance, gait) might worsen but return to normal levels during feasting. There was a general consensus that fasting is not safe for patients: on high doses of anti-convulsants, anti-spastics, and corticosteroids; with coagulopathy or active disease; during attacks; with EDSS score ≥7.Summary: These data suggest that MS patients should have tailored care. Fasting in MS patients is a challenge that is directly associated with the spiritual belief of the patient. © 2014 Jahromi et al.; licensee BioMed Central Ltd.
Related Docs
View other Related Docs
1. Effects of Prolonged Fasting on Fatigue and Quality of Life in Patients With Multiple Sclerosis, Neurological Sciences (2016)
2. Short-Term Effects of Prolonged Fasting on Multiple Sclerosis, European Neurology (2009)
3. The Effect of Fasting on Cerebral Venous and Dural Sinus Thrombosis, Neurological Research (2009)
4. Effects of Ramadan Fasting on Glucose Homeostasis, Lipid Profiles, Inflammation and Oxidative Stress in Women With Polycystic Ovary Syndrome in Kashan, Iran, Archives of Iranian Medicine (2015)
5. Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial, NeuroImmunoModulation (2014)
6. Effects of Anti-Inflammatory-Antioxidant-Rich Diet and Co-Supplemented Synbiotics Intervention in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Single-Blind Randomized Clinical Trial, Nutritional Neuroscience (2023)
7. Recommendations for Ramadan Fasting in Patients With Diabetes Mellitus Based on Integrative Medicine and According to the Persian Culture-A Review Study, Journal of Isfahan Medical School (2023)
8. Effect of Ms14® on Physical Activity of Multiple Sclerosis Patients: A Randomized Triple-Blind Placebo-Controlled Clinical Trial, Multiple Sclerosis and Related Disorders (2023)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (49)
Masoud Etemadifar (35)
Other Related Docs
9. Association Between Dietary Inflammatory Index and Risk of Demyelinating Autoimmune Diseases: A Cross-Sectional Study, International Journal for Vitamin and Nutrition Research (2024)
10. Potential of Modified Mediterranean Diet to Improve Quality of Life and Fatigue Severity in Multiple Sclerosis Patients: A Single-Center Randomized Controlled Trial, International Journal of Food Properties (2020)
11. Anti-Inflammatory-Antioxidant Modifications and Synbiotics Improved Health-Related Conditions in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Complementary Therapies in Clinical Practice (2023)
12. Modified Mediterranean Diet V. Traditional Iranian Diet: Efficacy of Dietary Interventions on Dietary Inflammatory Index Score, Fatigue Severity and Disability in Multiple Sclerosis Patients, British Journal of Nutrition (2022)
13. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
14. A Mediterranean-Type Diet Improved Systemic Inflammation in Multiple Sclerosis Patients, As Compared to the Traditional Iranian Diet: A Single-Center Randomized Controlled Trial, Mediterranean Journal of Nutrition and Metabolism (2021)
15. Association of Dietary Patterns With Systemic Inflammation, Quality of Life, Disease Severity, Relapse Rate, Severity of Fatigue and Anthropometric Measurements in Ms Patients, Nutritional Neuroscience (2020)
16. The Study of Circadian Rhythms Disorder and Its Relationship With Chronic Fatigue in Multiple Sclerosis in Compare With Control Group, Journal of Isfahan Medical School (2011)
17. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis, JAMA Neurology (2018)
18. Comparison of Prevalence Rates of Restless Legs Syndrome, Self-Assessed Risks of Obstructive Sleep Apnea, and Daytime Sleepiness Among Patients With Multiple Sclerosis (Ms), Clinically Isolated Syndrome (Cis) and Neuromyelitis Optica Spectrum Disorder (Nmosd), Sleep Medicine (2020)
19. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
20. Environmental Risk Factors for Multiple Sclerosis: A Case-Control Study in Kerman, Iran, Iranian Journal of Nursing and Midwifery Research (2018)
21. Tumefactive Rebound of Multiple Sclerosis After the Short-Term Cessation of Fingolimod: A Case Report, Multiple Sclerosis and Related Disorders (2020)
22. Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases, Journal of Central Nervous System Disease (2024)
23. A Comparative Study of 25 (Oh) Vitamin D Serum Levels in Patients With Multiple Sclerosis and Control Group in Isfahan, Iran, International Journal of Preventive Medicine (2010)
24. Contribution of Different Relapse Phenotypes to Disability in Multiple Sclerosis, Multiple Sclerosis (2017)
25. Prevalence of Hypothyroidism Among Patients With Multiple Sclerosis Referred to Multiple Sclerosis Clinic of Alzahra Hospital, Isfahan, Iran, During 2014-2015, Journal of Isfahan Medical School (2016)
26. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
27. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
28. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
29. Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis: A Randomized Clinical Trial, Acta Neurologica Scandinavica (2021)
30. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
31. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
32. Fasting Diets: What Are the Impacts on Eating Behaviors, Sleep, Mood, and Well-Being?, Frontiers in Nutrition (2023)
33. Ramadan Fasting and Risk of Covid-19, International Journal of Preventive Medicine (2020)
34. Comparison of the Effect of Aspirin and Amantadine for the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Blinded, Crossover Study, Neurological Research (2012)
35. The Association Between Multiple Sclerosis and Migraine: A Meta-Analysis, Multiple Sclerosis and Related Disorders (2023)
36. Circadian Rhythm Sleep Disorders in Patients With Multiple Sclerosis and Its Association With Fatigue: A Case-Control Study, Journal of Research in Medical Sciences (2013)
37. The Role of Nutritional Factors During Adolescence in Multiple Sclerosis Onset: A Population-Based Incident Case–Control Study, Nutritional Neuroscience (2021)
38. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, JAMA - Journal of the American Medical Association (2019)
39. The Effect of Fasting in Ramadan on the Values and Interrelations Between Biochemical, Coagulation and Hematological Factors, Annals of Saudi Medicine (2000)
40. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
41. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
42. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)
43. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
44. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
45. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
46. Side Effects of Methylprednisolone Pulse Therapy in Treatment of Multiple Sclerosis, Journal of Isfahan Medical School (2012)
47. Effectiveness of Multiple Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis: Causal Inference to Emulate a Multiarm Randomised Trial, Journal of Neurology, Neurosurgery and Psychiatry (2023)
48. Ramadan Fasting and Patients With Renal Diseases: A Mini Review of the Literature, Journal of Research in Medical Sciences (2013)
49. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
50. A Comparison of Linear and Nonlinear Stability Parameters in Different Clinical Forms of Multiple Sclerosis, European Review of Aging and Physical Activity (2015)